It takes time to develop expertise. This realization long encouraged the world's largest pharmaceutical firms to build and maintain in-house intellectual and technical capacities that served as source
Despite ambitions to become the “global category leader in oncology,” Astellas Pharma Inc. has decided to pull the plug on a promising collaboration in acute myeloid leukemia with privately held
IN VITRO DIAGNOSTICS Mergers & Acquisitions Roche Roche Professional Diagnostics Dynabyte Informationssysteme GMBH Verum Diagnostica GMBH Roche Professional Diagnostics (RPD; part of Roche) is p
In Vitro Diagnostics 23andMe Inc. J&J's venture arm joins backers in 23andMe's $22.2mm Series C Nov. —New investor Johnson & Johnson Development Corp. has joined current shareholders New Enterprise A